These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25166025)

  • 1. Vortioxetine for the treatment of major depressive disorder.
    Tritschler L; Felice D; Colle R; Guilloux JP; Corruble E; Gardier AM; David DJ
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):731-45. PubMed ID: 25166025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
    David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
    Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vortioxetine for the treatment of major depression.
    Dhir A
    Drugs Today (Barc); 2013 Dec; 49(12):781-90. PubMed ID: 24524096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.
    Al-Sukhni M; Maruschak NA; McIntyre RS
    Expert Opin Drug Saf; 2015 Aug; 14(8):1291-304. PubMed ID: 26022537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vortioxetine in the treatment of major depression].
    de Bartolomeis A; Fagiolini A; Maina G
    Riv Psichiatr; 2016; 51(6):215-230. PubMed ID: 27996982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.
    Dziwota E; Olajossy M
    Acta Pol Pharm; 2016 Nov; 73(6):1433-1437. PubMed ID: 29634095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vortioxetine (Brintellix) for depression.
    Med Lett Drugs Ther; 2013 Nov; 55(1430):93-5. PubMed ID: 24276501
    [No Abstract]   [Full Text] [Related]  

  • 8. What role for ▼vortioxetine?
    Drug Ther Bull; 2016 Mar; 54(3):30-3. PubMed ID: 26966120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vortioxetine: a New Treatment for Major Depressive Disorder.
    Connolly KR; Thase ME
    Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vortioxetine: a new antidepressant to treat depressive episodes].
    Colle R; Corruble E
    Encephale; 2016 Feb; 42(1):48-58. PubMed ID: 26358483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine.
    Orsolini L; Tomasetti C; Valchera A; Iasevoli F; Buonaguro EF; Fornaro M; Fiengo ALC; Martinotti G; Vellante F; Matarazzo I; Vecchiotti R; Perna G; Di Nicola M; Carano A; Di Bartolomeis A; De Giannantonio M; De Berardis D
    CNS Neurol Disord Drug Targets; 2017; 16(1):65-92. PubMed ID: 27781949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vortioxetine for the treatment of depression.
    Pearce EF; Murphy JA
    Ann Pharmacother; 2014 Jun; 48(6):758-65. PubMed ID: 24676550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review.
    De Diego-Adeliño J; Crespo JM; Mora F; Neyra A; Iborra P; Gutiérrez-Rojas L; Salonia SF
    Expert Opin Drug Saf; 2022 May; 21(5):673-690. PubMed ID: 34964415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vortioxetine: a review of its use in major depressive disorder.
    Garnock-Jones KP
    CNS Drugs; 2014 Sep; 28(9):855-74. PubMed ID: 25145538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of vortioxetine for the treatment of major depressive disorder.
    Dhir A; Sarvaiya J
    Expert Rev Neurother; 2014 Dec; 14(12):1349-63. PubMed ID: 25418918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
    Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Jaeschke RR; Sendek K; Styczeń K; Datka W; Koperny M
    Pharmacol Rep; 2017 Aug; 69(4):595-601. PubMed ID: 28499187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.
    Orsolini L; Tomasetti C; Valchera A; Iasevoli F; Buonaguro EF; Vellante F; Fornaro M; Fiengo A; Mazza M; Vecchiotti R; Perna G; de Bartolomeis A; Martinotti G; Di Giannantonio M; De Berardis D
    Expert Rev Neurother; 2016 May; 16(5):483-95. PubMed ID: 27050932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vortioxetine: A Review in Cognitive Dysfunction in Depression.
    Frampton JE
    Drugs; 2016 Nov; 76(17):1675-1682. PubMed ID: 27807822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vortioxetine: first global approval.
    Gibb A; Deeks ED
    Drugs; 2014 Jan; 74(1):135-45. PubMed ID: 24311349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of vortioxetine.
    Schatzberg AF; Blier P; Culpepper L; Jain R; Papakostas GI; Thase ME
    J Clin Psychiatry; 2014 Dec; 75(12):1411-8. PubMed ID: 25551236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.